Liza Yeo

Liza Yeo is an experienced investment manager currently serving at Uniseed since March 2024. In addition to this role, Liza holds several non-executive director positions at Celosia Therapeutics, ENA Respiratory, Currus Biologics Pty Ltd, Axelia Oncology, and Ferronova, all starting in 2024. Previous experience includes leadership roles in business development at Parexel from October 2017 to March 2024, and project management in the oncology sector at INC Research from April 2010 to September 2016. Earlier positions include Country Study Manager for Roche in the Asia Pacific region and Global Studies Associate responsible for managing global studies. Liza holds an Honours degree in Pharmacy from the National University of Singapore, as well as 'A' Levels and 'O' Levels from Hwa Chong Junior College and Methodist Girls' School, respectively.